Double Therapy With IFN-beta 1b and Hydroxychloroquine

NCT04350281 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

COVID

Interventions

DRUG: Interferon Beta-1B
DRUG: Hydroxychloroquine

Sponsor

The University of Hong Kong